ALB and hepatocellular carcinoma: When the residual liver function of all patients was stratified according to the albumin–bilirubin (ALBI) grade [30], the 5-year risk of developing HCC was not significantly different in each ALBI grade (p = 0.30 by the log-rank test): HCC developed within 5 years in 6.9% of patients in ALBI grade 1 (n = 145), 7.3% of patients in ALBI grade 2 (n = 522), and 5.9% of patients in ALBI grade 3 (n = 410).